BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36454046)

  • 1. FLI-1/Melan-A dual stain is an alternative to PRAME in differentiating metastatic melanoma from nodal nevus: A monocentric retrospective study.
    Zengin HB; Yildiz B; Pukhalskaya T; Smoller BR
    J Cutan Pathol; 2023 Mar; 50(3):247-258. PubMed ID: 36454046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.
    Lezcano C; Pulitzer M; Moy AP; Hollmann TJ; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Apr; 44(4):503-508. PubMed ID: 31633488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
    Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
    J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.
    Saab J; Santos-Zabala ML; Loda M; Stack EC; Hollmann TJ
    Am J Dermatopathol; 2018 Apr; 40(4):259-264. PubMed ID: 28654463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
    Siref AB; Huynh CAT; Balzer BL; Frishberg DP; Essner R; Shon W
    J Cutan Pathol; 2019 Apr; 46(4):261-266. PubMed ID: 30632191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
    Chen PL; Chen WS; Li J; Lind AC; Lu D
    Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors.
    Rasic D; Korsgaard N; Marcussen N; Precht Jensen EM
    Ann Diagn Pathol; 2023 Dec; 67():152211. PubMed ID: 37717457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
    Lohman ME; Steen AJ; Grekin RC; North JP
    J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
    Du J; Yu WJ; Guo RP; Su J
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
    [No Abstract]   [Full Text] [Related]  

  • 13. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
    Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
    Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
    Lee JJ; Granter SR; Laga AC; Saavedra AP; Zhan Q; Guo W; Xu S; Murphy GF; Lian CG
    Mod Pathol; 2015 Feb; 28(2):218-29. PubMed ID: 25081754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining the application of PRAME-a useful marker in high CSD and acral melanoma subtypes.
    Wakefield C; O'Keefe L; Heffron CCBB
    Virchows Arch; 2023 Dec; 483(6):847-854. PubMed ID: 37723345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME immunohistochemistry of spitzoid neoplasms.
    Koh SS; Lau SK; Scapa JV; Cassarino DS
    J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.
    Shidham VB; Qi D; Rao RN; Acker SM; Chang CC; Kampalath B; Dawson G; Machhi JK; Komorowski RA
    BMC Cancer; 2003 May; 3():15. PubMed ID: 12735792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.